ASO GROUP Ltd Invests $802,000 in Veeva Systems Inc. $VEEV

ASO GROUP Ltd acquired a new position in Veeva Systems Inc. (NYSE:VEEV) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 3,594 shares of the technology company’s stock, valued at approximately $802,000.

Other institutional investors have also made changes to their positions in the company. Robeco Institutional Asset Management B.V. increased its stake in shares of Veeva Systems by 11.3% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 892,070 shares of the technology company’s stock worth $199,137,000 after purchasing an additional 90,703 shares during the period. Elo Mutual Pension Insurance Co grew its position in Veeva Systems by 50.2% during the third quarter. Elo Mutual Pension Insurance Co now owns 26,541 shares of the technology company’s stock worth $7,907,000 after buying an additional 8,869 shares in the last quarter. Empire Life Investments Inc. grew its position in Veeva Systems by 21.1% during the fourth quarter. Empire Life Investments Inc. now owns 37,054 shares of the technology company’s stock worth $8,272,000 after buying an additional 6,453 shares in the last quarter. Alliancebernstein L.P. grew its position in Veeva Systems by 4.1% during the third quarter. Alliancebernstein L.P. now owns 5,941,631 shares of the technology company’s stock worth $1,770,071,000 after buying an additional 235,983 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its position in Veeva Systems by 217.2% during the fourth quarter. Farther Finance Advisors LLC now owns 10,470 shares of the technology company’s stock worth $2,337,000 after buying an additional 7,169 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares in the company, valued at approximately $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva’s latest quarter was described as strong, with broad-based customer demand, solid execution across R&D and commercial products, and continued momentum in Vault CRM migrations and AI-driven offerings. Reasons to Add Veeva Systems Stock to Your Portfolio for Now
• Positive Sentiment: The company continues to expand its AI strategy, including the Falcon platform and “agentic labor” tools, which management says could improve automation and deepen its competitive moat in life sciences software. The 5 Most Interesting Analyst Questions From Veeva Systems’s Q1 Earnings Call
• Positive Sentiment: Veeva announced that UCB is standardizing global pharmacovigilance operations on the Veeva Safety Suite, reinforcing customer adoption of its regulated-cloud products. UCB vereinheitlicht seine weltweiten Pharmakovigilanz-Aktivitäten mit der Veeva Safety Suite
• Neutral Sentiment: Several recent articles say VEEV is one of the most watched stocks on Zacks, suggesting rising investor interest, but these pieces do not point to a specific new catalyst. Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
• Neutral Sentiment: One article noted the stock remains well below its prior highs after a steep one-year decline, which may support a value/rebound narrative but also reflects lingering investor caution. Is It Time To Revisit Veeva Systems (VEEV) After A 41% One Year Share Price Decline
• Negative Sentiment: Despite the upbeat product and earnings backdrop, analysts and commentary continue to flag saturation risk in the life sciences CRM market, which could limit long-term upside. Reasons to Add Veeva Systems Stock to Your Portfolio for Now

Veeva Systems Trading Down 1.4%

NYSE VEEV opened at $161.54 on Friday. The stock’s 50 day moving average is $165.32 and its two-hundred day moving average is $192.34. The company has a market capitalization of $26.38 billion, a price-to-earnings ratio of 28.80, a PEG ratio of 0.70 and a beta of 0.95. Veeva Systems Inc. has a 1-year low of $148.05 and a 1-year high of $310.50.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. The company had revenue of $882.95 million for the quarter, compared to the consensus estimate of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The company’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.97 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. On average, analysts predict that Veeva Systems Inc. will post 6.65 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms recently weighed in on VEEV. Needham & Company LLC reissued a “buy” rating and set a $270.00 target price on shares of Veeva Systems in a research report on Thursday, June 4th. Mizuho decreased their target price on Veeva Systems from $295.00 to $270.00 and set an “outperform” rating on the stock in a research report on Thursday, June 4th. William Blair reissued an “outperform” rating on shares of Veeva Systems in a research report on Tuesday, March 10th. Royal Bank Of Canada reissued an “outperform” rating and set a $275.00 target price on shares of Veeva Systems in a research report on Thursday, June 4th. Finally, Wells Fargo & Company lifted their target price on Veeva Systems from $317.00 to $320.00 and gave the stock an “overweight” rating in a research report on Thursday, June 4th. Eighteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $250.96.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.